What is BDSX (BDSX) stock price today?

BDSX (BDSX) is currently trading at $20.38, down 3.09% today.

What is BDSX P/E ratio?

BDSX's P/E ratio is -2.82. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BDSX return on equity (ROE)?

BDSX's return on equity (ROE) is -383.09%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is BDSX's market cap?

BDSX has a market capitalization of $165.90M.

NGM · Medical - Diagnostics & Research

BDSX (BDSX) Stock

$20.38 -3.09% NGM: BDSX Healthcare

Valuation

Metric	Value
Price	$20.38
Market Cap	$165.90M
P/E Ratio	-2.82
P/B Ratio	10.66
P/S Ratio	1.25
EPS (TTM)	$-4.67
52-Week High	$24.65
52-Week Low	$5.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-383.09%
ROA	-18.79%
ROCE	933.33%
Gross Margin	81.11%
Operating Margin	-6.84%
Net Margin	-33.26%
Debt/Equity	7.84
Current Ratio	1.87

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$55.0M	$38.0M	$49.0M	$71.0M	$88.0M
Operating Profit	$-41.0M	$-51.0M	$-41.0M	$-34.0M	$-28.0M
Net Profit	$-43.0M	$-65.0M	$-52.0M	$-43.0M	$-35.0M
EPS	$-31.60	$-31.00	$-12.80	$-6.60	$-4.67
Op Margin	-75.1%	-132.4%	-84.2%	-48.4%	-31.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$76.0M	$93.0M	$99.0M	$97.0M	$87.0M
Total Liabilities	$56.0M	$72.0M	$95.0M	$76.0M	$90.0M
Cash	$33.0M	$43.0M	$26.0M	$26.0M	$19.0M
Borrowings	$10.0M	$32.0M	$61.0M	$62.0M	$73.0M

Latest News

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? Zacks · Jul 1, 2026 Biodesix (BDSX) Stock Gets Fair Value Bump As Analysts Back Growth Path Simply Wall St. · Jun 26, 2026 Roth Capital Initiates Biodesix at Buy With $32 Price Target MT Newswires · Jun 25, 2026 Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains? Zacks · Jun 19, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-28.0M	$-45.0M	$-23.0M	$-49.0M	$-23.0M
Investing Cash Flow	$-5.0M	$-7.0M	$-46.0M	$-7.0M	$-1.0M
Financing Cash Flow	$0	$-17.0M	$-9.0M	$-4.0M	$-1.0M
Net Cash Flow	$-30.0M	$10.0M	$-17.0M	$0	$-7.0M
Free Cash Flow	$-31.0M	$-49.0M	$-46.0M	$-52.0M	$-24.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-15.79
EV / EBITDA	-8.40
FCF Yield	-20.93%
Quick Ratio	2.82
Interest Coverage	-3.50
Return 1Y	237.54%
Return 3Y	-4.82%
Return 5Y	-90.92%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About BDSX

BDSX is led by CEO Scott Hutton, employs 273 people, headquartered in US, publicly traded since 2020.

BDSX stock trades at $20.38 with a market capitalization of $165.90M. The stock is valued at a price-to-earnings (P/E) ratio of -2.82, price-to-book of 10.66, price-to-sales of 1.25. Over the past 52 weeks the stock has ranged between $5.00 and $24.65, and currently trades 17.3% below its 52-week high.

On profitability, BDSX generates a return on equity (ROE) of -383.09%, return on capital employed of 933.33%, an operating margin of -6.84%, a net profit margin of -33.26%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides